P-55

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-55
Drug Alias NameP-55
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionInterleukin-4 receptors inhibitorsInterleukin-2 receptor antagonistsImmunoglobulin epsilon Fc receptor antagonists
TargetsInterleukin-4 receptorsInterleukin-2 receptorImmunoglobulin epsilon Fc receptor
Therapy Area/IndicationsEczema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIXICO plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIXICO plc
Active IndicationsN/A
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A